Evaluation of the safety, reactogenicity and immunogenicity of three recombinant outer surface protein (OspA) lyme vaccines in healthy adults

By Van Hoecke C.   Comberbach M.   De Grave D.   Desmons P.   Fu D.   Hauser P.   Lebacq E.   Lobet Y.   Voet P.  

Vaccine, Vol. 14, Iss. 17, 1996-12 ,pp. : 1620-1626

Elsevier

Access to resources Recommend Favorite

The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi

By Golde W.T.   Burkot T.R.   Piesman J.   Dolan M.C.   Capiau C.   Hauser P.   Dequesne G.   Lobet Y.  

Vaccine, Vol. 13, Iss. 5, 1995-01 ,pp. : 435-441

Elsevier

Access to resources Recommend Favorite

The outer surface protein A (OspA) vaccine against Lyme disease: efficacy in the rhesus monkey

By Philipp M.T.   Lobet Y.   Bohm R.P.   Roberts E.D.   Dennis V.A.   Gu Y.   Lowrie R.C.   Desmons P.   Duray P.H.   England J.D.   Hauser P.   Piesman J.   Xu K.  

Vaccine, Vol. 15, Iss. 17, 1997-12 ,pp. : 1872-1887

Elsevier

Access to resources Recommend Favorite

Induction of protective immune responses against Venezuelan equine encephalitis (VEE) virus aerosol challenge with microencapsulated VEE virus vaccine

By Greenway T.E.   Eldrige J.H.   Ludwig G.   Staas J.K.   Smith J.F.   Gilley R.M.   Michalek S.M.  

Vaccine, Vol. 16, Iss. 13, 1998-08 ,pp. : 1314-1323

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of recombinant Bacille Calmette-Guerin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccine

By Edelman R.   Palmer K.   Russ K.G.   Secrest H.P.   Anna L. Becker J.   Bodison S.A.   Perry J.G.   Sills A.R.   Barbour A.G.   Luke C.J.   Hanson M.S.   Stover C.K.   Burlein J.E.   Bansal G.P.   Connor E.M.   Koenig S.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 904-914

Elsevier

Access to resources Recommend Favorite